PACB - Pacific Biosciences of California, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue93,46890,71492,782
Cost of Revenue58,80946,55439,332
Gross Profit34,65944,16053,450
Operating Expenses
Research Development65,32467,61760,440
Selling General and Administrative59,11947,78722,144
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-89,784-71,244-29,134
Income from Continuing Operations
Total Other Income/Expenses Net516103364
Earnings Before Interest and Taxes-89,268-71,141-28,770
Interest Expense2,9213,2342,926
Income Before Tax-92,189-74,375-31,696
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-92,189-74,375-31,696
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-92,189-74,375-31,696
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-92,189-74,375-31,696